These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10726053)

  • 21. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
    Kamal SM; Graham CS; He Q; Bianchi L; Tawil AA; Rasenack JW; Khalifa KA; Massoud MM; Koziel MJ
    J Infect Dis; 2004 Apr; 189(7):1140-50. PubMed ID: 15031780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C.
    Kiefersauer S; Reiter C; Eisenburg J; Diepolder HM; Rieber EP; Riethmüller G; Gruber R
    J Immunol; 1997 Oct; 159(8):4064-71. PubMed ID: 9378996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis C infection--mechanisms of virus "immune escape"].
    Nitkiewicz J
    Przegl Epidemiol; 2004; 58(3):423-33. PubMed ID: 15730006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immune responses against hepatitis C virus.
    Koziel MJ
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S25-31. PubMed ID: 16265610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome.
    Racanelli V; Manigold T
    Clin Immunol; 2007 Jul; 124(1):5-12. PubMed ID: 17540619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia.
    Yao P; Hu X; Hu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):227-30. PubMed ID: 11498684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
    Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
    Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response.
    Pilli M; Penna A; Zerbini A; Vescovi P; Manfredi M; Negro F; Carrozzo M; Mori C; Giuberti T; Ferrari C; Missale G
    Hepatology; 2002 Dec; 36(6):1446-52. PubMed ID: 12447871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
    J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women.
    Della Bella S; Riva A; Tanzi E; Nicola S; Amendola A; Vecchi L; Nebbia G; Longhi R; Zanetti AR; Villa ML
    J Hepatol; 2005 Sep; 43(3):394-402. PubMed ID: 16023248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.
    Barnes E; Harcourt G; Brown D; Lucas M; Phillips R; Dusheiko G; Klenerman P
    Hepatology; 2002 Sep; 36(3):743-54. PubMed ID: 12198669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.